(/) Home (/) » Clinical Trials (/clinical-trials/) » Search Clinical Trials (/clinical-trials/listings/) Therapeutic Areas: | Oncology (/clinical-trials/listings/therapeutic-area/12/oncology/) | Otolaryngology (Ear, Nose, Throat) (/clinical-trials/listings/therapeuticarea/14/otolaryngology-ear-nose-throat/) | Pulmonary/Respiratory Diseases (/clinical-trials/listings/therapeutic-area/18/pulmonary-respiratory-diseases/) | Family Medicine (/clinical-trials/listings/therapeutic-area/23/family-medicine/)
Esophageal Cancer Clinical Trials
SEARCH FILTERS
A listing of Esophageal Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find SEARCH MEDICAL CONDITION Esophageal Cancer
more detailed information on a research study in your area.
RESULTS
Enter a location * Within
« (?page=1)
←
3 (?page=3)
4 (?page=4)
6 (?page=6)
Õ (?page=2)
1
2 (?page=2) 5 (?page=5)
» (?page=31)
---
Found (301) clinical trials
Search
Dose-escalation Study of BAY1129980
TRIAL FILTERS
(/clinical-trials/listings/62525/neoplasms-dose-escalation-study-bay1129980/?&radius=50)
The relatively restricted C4.4a expression pattern provides a target for the selective delivery of a cytotoxic GENDER Both (?&gender=Both)
drug to C4.4.a-expressing tumor cells by means of a suitable antibody-drug conjugate. The subject 300 1
N/A (?&gender=na )
population eligible for the current study will be those subjects with advanced malignancies known to express C4.4a, which are refractory ... Phase
Learn More » (/clinical-trials/listings/62525/neoplasms-dose-escal STUDY TYPE Interventional (? &study_type=Interventional) 236
Observational (?
SWOG S1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for
&study_type=Observational) 61
Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer (/clinical-trials/listings/136249/swog-s1201-a-randomized-phase-ii-pilot-study-prospectively-evaluating-treatment-for-
TRIAL PHASE
patients-based-on-ercc1excision-repair-cross-complementing-1-for-advancedmetastatic-esophageal-gastric-orPhase 1 (?&phase=1)
27
Phase 2 (?&phase=2)
78
Phase 3 (?&phase=3)
34
Phase 4 (?&phase=4)
6
Phase 1/2 (?&phase=5)
21
Phase 2/3 (?&phase=6)
7
Unknown (?&phase=-1)
128
gastroesophageal-junction-gej-cancer-2/?&radius=50)
For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01498289? term=SWOG+S1201&rank=1 Phase
Learn More » (/clinical-trials/listings/136249/swog-s1201-a-random
Esophageal or Gastroesophageal Junction Cancer (/clinical-trials/listings/151117/esophageal-or-gastroesophageal-junction-cancer-2/?&radius=50)
People with Esophageal or Gastroesophageal Junction Cancer are asked to participate in a research
study being conducted by Montefiore Medical Center. Phase N/A
Learn More » (/clinical-trials/listings/151117/esophageal-or-gastro
A Randomised Phase III Double-Blind Placebo-Controlled Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) (/clinical-trials/listings/153189/a-randomised-phase-iii-double-blind-placebo-controlled-study-of-regorafenib-inrefractory-advanced-gastro-oesophageal-cancer-agoc-2/?&radius=50)
Advanced Gastro-oesophageal Carcinoma (AGOC) has a poor prognosis, and there is no established standard treatment following failure of first and second line chemotherapy. Regorafenib (BAY 73-4506) is an investigational oral multi-targeted tyrosine kinase inhibitor (TKI) which targets angiogenic (VEGF, TIE2), stromal (PDGF-ß), and oncogenic (RAF, RET and KIT) receptor tyrosine ... Phase
Learn More » (/clinical-trials/listings/153189/a-randomised-phase-
Persistent Local Esophageal Cancer (/clinical-trials/listings/155583/persistent-local-esophageal-cancer/?&radius=50)
People with esophageal cancer are asked to participate in a research study being conducted by North Shore University Hospital. Phase N/A
Learn More » (/clinical-trials/listings/155583/persistent-local-esoph
International Nutrition Audit in FORegut TuMors (/clinical-trials/listings/96902/head-and-neck-cancer-international-nutrition-audit-foregut/?&radius=50)
The proposed project is a prospective inception cohort study of current nutrition practices of patients with foregut tumors (esophageal and/or head & neck cancer) in cancer care settings in Canada, Europe and Australia. This multi center study will involve a baseline audit of current nutrition practice, followed by repeated audit ... Phase N/A
Learn More » (/clinical-trials/listings/96902/head-and-neck-cancer
Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer (/clinical-trials/listings/99114/superficial-esophageal-cancer-human-autologous-oral-mucosal/?&radius=50)
This study is a multicenter, single-arm, open-label study of CLS2702C/D in patients who plan to undergo ESD for superficial esophageal cancer. In this study, the efficacy and safety of CLS2702C (cell sheet) transplanted (applied) to the wound site after ESD using CLS2702D (transplantation device) will be evaluated. Phase
Learn More » (/clinical-trials/listings/99114/superficial-esophageal
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors (/clinical-trials/listings/99317/ny-eso-1-expressing-solid-tumors-in-hla-a2-positive-patients-study-tbi-1301-ny-eso-1specific/?&radius=50)
The target populations for this phase I study with TBI-1301 are patients with advanced solid tumors. Patients' tumors will be required to express NY-ESO-1, which include but is not limited to ovarian cancer, synovial sarcoma, esophageal cancer and malignant melanoma. Patients must be positive for HLA-A02:01 or HLA-A02:06 and the ... Phase
Learn More » (/clinical-trials/listings/99317/ny-eso-1-expressing-so
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients (/clinical-trials/listings/104784/gastric-cancer-study-pre-operative-combination-therapy/?&radius=50)
To assess the safety of preoperative combination therapy with KW-0761 (anti-CCR4) and ONO-4538 (antiPD-1). To assess the behavior of immune cells in peripheral blood and tumor. Phase
Learn More » (/clinical-trials/listings/104784/gastric-cancer-study-p
Durvalumab an Anti-PD-L1 Antibody and Chemoradiation Before Surgery for Esophageal Cancer (/clinical-trials/listings/106044/esophageal-adenocarcinoma-durvalumab-an-anti-pd-l1/?&radius=50)
The purpose of this study is to test the safety of adding a new drug, durvalumab (also called MEDI4736), to chemoradiation using two standard chemotherapy drugs, carboplatin and paclitaxel. The investigators want to find out what effects, good and/or bad, this combination has on the patient and cancer. Phase
Learn More » (/clinical-trials/listings/106044/esophageal-adenocar
« (?page=1)
←
3 (?page=3)
4 (?page=4)
6 (?page=6)
Õ (?page=2)
1
2 (?page=2) 5 (?page=5)
» (?page=31) Powered by Copyright © 1995-2018 CenterWatch.
(http://www.trialx.com)
Contact Us (/contact/) Privacy (/about-centerwatch/privacy.aspx) Glossary (/health-resources/glossary/) Site Map (/sitemap.aspx)